Antimicrob Agents Chemother
- PETRAITIS V, Petraitiene R, Kavaliauskas P, Naing E, et al
Development of rabbit models of ventilator-associated bacterial pneumonia
produced by carbapenem-resistant Pseudomonas aeruginosa.
Antimicrob Agents Chemother. 2024 Apr 30:e0020524. doi: 10.1128/aac.00205.
- SUN L, Zhuang H, Chen M, Chen Y, et al
Vancomycin heteroresistance caused by unstable tandem amplifications of the vanM
gene cluster on linear conjugative plasmids in a clinical Enterococcus faecium.
Antimicrob Agents Chemother. 2024 Mar 20:e0115923. doi: 10.1128/aac.01159.
- SUZUKI D, Sakurai A, Wakuda M, Suzuki M, et al
Clinical and genomic characteristics of IMP-producing Enterobacter cloacae
complex and Klebsiella pneumoniae.
Antimicrob Agents Chemother. 2024;68:e0167223.
- XIA L, Li Y, Wang Y, Zhou H, et al
Quorum-sensing regulation of phenazine production heightens Pseudomonas
aeruginosa resistance to ciprofloxacin.
Antimicrob Agents Chemother. 2024;68:e0011824.
- CASTANHEIRA M, Kimbrough JH, Lindley J, Doyle TB, et al
In vitro development of resistance against antipseudomonal agents: comparison of
novel beta-lactam/beta-lactamase inhibitor combinations and other beta-lactam agents.
Antimicrob Agents Chemother. 2024;68:e0136323.
- GHOSH S, Orman MA
Exploring the links between SOS response, mutagenesis, and resistance during the
recovery period.
Antimicrob Agents Chemother. 2024;68:e0146223.
- ISHII M, Yamada T, Ishikawa K, Ichinose K, et al
The Ptk2-Pma1 pathway enhances tolerance to terbinafine in Trichophyton rubrum.
Antimicrob Agents Chemother. 2024;68:e0160923.
- MILLER AA, Moussa SH, McLeod SM
Characterization of Acinetobacter baumannii-calcoaceticus complex isolates and
microbiological outcome for patients treated with sulbactam-durlobactam in a
phase 3 trial (ATTACK).
Antimicrob Agents Chemother. 2024;68:e0169823.
- VEGA AD, DeRonde K, Jimenez A, Piazza M, et al
Difficult-to-treat (DTR) Pseudomonas aeruginosa harboring Verona-Integron
metallo-beta-lactamase (bla(VIM)): infection management and molecular analysis.
Antimicrob Agents Chemother. 2024;68:e0147423.
- SCHALKWIJK HH, Shewakramani NR, Das K, Andrei G, et al
Combination of ganciclovir and trifluridine prevents drug-resistance emergence in
HSV-1.
Antimicrob Agents Chemother. 2024;68:e0011024.
- NIELSEN TK, Petersen IB, Xu L, Barbuti MD, et al
The Spx stress regulator confers high-level beta-lactam resistance and decreases
susceptibility to last-line antibiotics in methicillin-resistant Staphylococcus
aureus.
Antimicrob Agents Chemother. 2024 May 1:e0033524. doi: 10.1128/aac.00335.
Int J Antimicrob Agents
- ZHUANG H, Chen M, Hu D, Liu L, et al
Role of tcaA, a potential target as a ceftobiprole resistance breaker, in MRSA
beta-lactam resistance.
Int J Antimicrob Agents. 2024 Apr 29:107185.
- RUSSO A, Gulli SP, D'Avino A, Borrazzo C, et al
Intravenous fosfomycin for treatment of severe infections caused by
carbapenem-resistant Acinetobacter baumannii: a multicenter clinical experience.
Int J Antimicrob Agents. 2024 Apr 30:107190.
- AMODIO E, Pizzo S, Vella G, De Francisci V, et al
Increase of multidrug-resistant bacteria after the COVID-19 pandemic in a major
teaching Hospital in Sicily (2018-2021).
Int J Antimicrob Agents. 2024;63:107123.
- HSU CK, Lai CC, Chen CC, Chen HJ, et al
Evaluation of three brands of Mueller-Hinton media for broth microdilution method
to determine the susceptibility of multidrug-resistant Gram-negative bacilli
against eravacycline.
Int J Antimicrob Agents. 2024;63:107117.
- WANG L, Zhou X, Lu Y, Zhang X, et al
Levofloxacin-induced MexS mutation triggers imipenem-relebactam resistance in a
KPC-producing Pseudomonas aeruginosa.
Int J Antimicrob Agents. 2024;63:107119.
- ATHANASSA Z, Manioudaki S, Petsa I, Koumaki V, et al
Effectiveness and safety of minocycline combination therapy for the treatment of
patients with ventilator-associated pneumonia due to extensively drug- or
pandrug-resistant Acinetobacter baumannii.
Int J Antimicrob Agents. 2024;63:107129.
- MEZCORD V, Traglia GM, Pasteran F, Escalante J, et al
Characterisation of cefiderocol-resistant spontaneous mutant variants of
Klebsiella pneumoniae-producing NDM-5 with a single mutation in cirA.
Int J Antimicrob Agents. 2024;63:107131.
- MESCHIARI M, Faltoni M, Kaleci S, Tassoni G, et al
Intravenous fosfomycin in combination regimens as a treatment option for
difficult-to-treat infections due to multi-drug-resistant Gram-negative
organisms: A real-life experience.
Int J Antimicrob Agents. 2024;63:107134.
- LONG H, Zhao F, Feng Y, Zong Z, et al
Global distribution of bla(CMY-42), a gene mediating reduced susceptibility to
aztreonam-avibactam and ceftazidime-avibactam, in Escherichia coli.
Int J Antimicrob Agents. 2024;63:107141.
- MONTE DFM, de Oliveira CJB
Silent dissemination of fosfomycin resistance genes in critical-priority
Klebsiella pneumoniae.
Int J Antimicrob Agents. 2024;63:107139.
- XU H, Tan C, Li C, Li J, et al
ESBL-Escherichia coli extracellular vesicles mediate bacterial resistance to
beta-lactam and mediate horizontal transfer of bla(CTX-M-55).
Int J Antimicrob Agents. 2024;63:107145.
- LIM C, Coombs GW, Daley DA, Shoby P, et al
Whole-genome sequencing identifies MprF mutations in a genetically diverse
population of daptomycin non-susceptible Staphylococcus aureus in Australia.
Int J Antimicrob Agents. 2024;63:107144.
- YANG W, Tang C, Shen S, Shi Q, et al
Spread and evolution of bla(KPC)-plasmid between Serratia marcescens and
Klebsiella pneumoniae.
Int J Antimicrob Agents. 2024;63:107149.
- DE OLIVEIRA HC, Santos MDM, Camillo-Andrade AC, Castelli RF, et al
Proteomics reveals that the antifungal activity of fenbendazole against
Cryptococcus neoformans requires protein kinases.
Int J Antimicrob Agents. 2024;63:107157.
J Antimicrob Chemother
- ATAMNA A, Yeshurun M, Shargian L, Raanani P, et al
Fatal invasive pulmonary and cerebral aspergillosis due to triazole-resistant
Aspergillus fumigatus with multiple CYP51A mutations.
J Antimicrob Chemother. 2024 Feb 9:dkae038. doi: 10.1093.
- UNEMO M, Golparian D, Oxelbark J, Kong FYS, et al
Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125-1 g) to
eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae
strains in a hollow fibre infection model for gonorrhoea.
J Antimicrob Chemother. 2024;79:1006-1013.
- MALLART E, Guerin F, Amoura A, Le Scouarnec M, et al
Impact of the phenotypic expression of temocillin resistance in Escherichia coli
on temocillin efficacy in a murine peritonitis model.
J Antimicrob Chemother. 2024;79:1051-1059.
- GALANI I, Souli M, Katsala D, Karaiskos I, et al
In vitro activity of apramycin (EBL-1003) in combination with colistin,
meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii
isolates from Greece.
J Antimicrob Chemother. 2024;79:1101-1108.
- TESSIER E, Ruffier d'Epenoux L, Lartigue MF, Chaufour L, et al
Comparison of the in vitro activities of delafloxacin and comparators against
Staphylococcus epidermidis clinical strains involved in osteoarticular
infections: a CRIOGO multicentre retrospective study.
J Antimicrob Chemother. 2024 Mar 20:dkae071. doi: 10.1093.
- AGHOKENG AF, Ngo-Giang-Huong N, Huynh THK, Dagnra AY, et al
Prevalence of pretreatment HIV resistance to integrase inhibitors in West African
and Southeast Asian countries.
J Antimicrob Chemother. 2024;79:1164-1168.
- CHEN GJ, Cheng CY, Yang CJ, Lee NY, et al
Trends of pre-treatment drug resistance in antiretroviral-naive people with HIV-1
in the era of second-generation integrase strand-transfer inhibitors in Taiwan.
J Antimicrob Chemother. 2024;79:1157-1163.
- PANG X, He Q, Tang K, Huang J, et al
Drug resistance and influencing factors in HIV-1-infected individuals under
antiretroviral therapy in Guangxi, China.
J Antimicrob Chemother. 2024;79:1142-1152.
- BUZON-MARTIN L, Navarro-San Francisco C, Fernandez-Regueras M, Sanchez-Gomez L, et al
Integrase strand transfer inhibitor resistance mediated by R263K plus E157Q in a
patient with HIV infection treated with bictegravir/tenofovir
alafenamide/emtricitabine: case report and review of the literature.
J Antimicrob Chemother. 2024;79:1153-1156.
PLoS Genet
- NAGARAJAN A, Scoggin K, Gupta J, Aminian M, et al
Collaborative Cross mice have diverse phenotypic responses to infection with
Methicillin-resistant Staphylococcus aureus USA300.
PLoS Genet. 2024;20:e1011229.
PLoS One
- SHEN X, Zhu X, Liu H, Yuan R, et al
Leveraging genomic signatures of oral microbiome-associated antibiotic resistance
genes for diagnosing pancreatic cancer.
PLoS One. 2024;19:e0302361.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016